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safety and departmental efﬁciencies can be realized with a glass
to polymer bottle conversion.
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OBJECTIVES: To analyze and evalue the economic impact of
cost of stored medicines at home. METHODS: The population
to investigating is constituted by 146,396 homes. The size mues-
tral calculated was 196 homes (alpha error = 0,05; conﬁdence
level 95%). The studied variables were: n persons who compose
the home; n 65 years older; n of stored medicines and classes;
sociocultural level; symptoms of disease in 15 days before the
interview; n of persons with chronic disease and type; etc. The
statistical analysis was made by the SPSS package. For quanti-
tative: mean, DS, IC95%; for qualitative: proportions. For the
analysis multivariante Student’s T-test for quantitative variables
and test of Chi-square for the qualitative ones. For the calcula-
tion of the cost of medicines stored in the homes one has con-
sidered 2 values: the cost of the found medication (price sales)
and the real value of this medication (considering the amount of
present medicine in the package at the moment of the interview).
RESULTS: The total number of polled homes was of 360. The
members average for home was of 3.9 (IC95% 3.8–4,0). The
total of found pharmaceutical specialities was 8.544, of them
61% was ﬁnanced by the NHS, and of ﬁnanced ones 26.5% and
12.6% they were not bought with and without medical pre-
scription, respectively. The average value for pharmaceutical spe-
cialities stored was €130.5/home (IC95%: 121.48–139.48).
CONCLUSIONS: A high percentage of medication exists stored
(12.6%) that in spite of needing medical prescription did not
have it. The self medication increases with the level of studies.
Almost 75% of the stored medication was not used by any
member of the home, and almost 11% they were expired medi-
cines. The total cost of medicines stored in our city can range
between €11–13 million (10% of the whole of expense in med-
icines in Malaga).
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PATIENT SATISFACTION WITH THE PHARMACY FIRST
MINOR AILMENTS SCHEME
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OBJECTIVES: As part of the UK Government priorities to
improve access for people in primary care, the ‘Pharmacy First
Minor Ailments’ scheme was introduced by Nottingham City
Primary Care Trust in December 2003. People can ask for the
service, covering 12 minor ailments, at any participating phar-
macy and those who are exempt from NHS prescription charges
can receive the scheme’s formulary medicines free of charge. This
study aimed to measure the users’ satisfaction with the scheme.
METHODS: Questionnaires were distributed to scheme users
between May and December 2005. Satisfaction was measured
using ﬁve-point Likert scales for 24 items across eight dimen-
sions: general satisfaction, access/convenience, quality of drug,
physical environment, pharmacist’s competence, communica-
tion, interpersonal aspect and time spent with pharmacist. 
Individual dimension and overall satisfaction scores for each
respondent was calculated by summing the appropriate individ-
ual items scores. RESULTS: A total of 143 questionnaires were
completed (response rate 14%). Most respondents were white
women and the mean age was 33 years (range 17–62). Approx-
imately half of respondents had annual household income below
10,000 GBP. Most respondents were not economically active
with 36% looking after family and 25% unemployed. The mean
satisfaction score was 99.7 (SD 11.4, range 67–120, possible
score 24–120). The highest satisfaction score was reported for
access/convenience dimension and the lowest satisfaction with
the physical environment. Comparisons of overall satisfaction
scores did not demonstrate signiﬁcant differences with regard to
gender, age, ethnicity, educational level, employment and fre-
quency of using the service. However, those with a lower income
had signiﬁcantly higher overall satisfaction scores (ANOVA, F =
3.272, p = 0.042). CONCLUSIONS: Findings demonstrated a
high level of satisfaction with the ‘Pharmacy First Minor Ail-
ments’ scheme, particularly for those with lower incomes. Thus
the scheme can be seen as a successful way of improving access
to primary care in Nottingham City PCT.
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OBJECTIVES: Needle punctures are an occupational hazard for
health care workers and others. This analysis was performed to
assess use and associated costs of Emergency Department (ED)
care for work-related needle punctures. METHODS: 2001–2003
statewide Massachusetts ED visit databases were analyzed.
Work-related needle punctures were identiﬁed using diagnosis
codes, E-code 920.5 (accidental cutting/ piercing with hypoder-
mic needle) and a primary payer code indicating workmen’s com-
pensation. Cost estimates (2006 US$) include facility, ancillary
and physician services. ED charges were adjusted using 0.55
cost-to-charge ratio, appropriate inﬂation indices and geographic
factors to reﬂect U.S. national values. RESULTS: Over the three
years, 5288 ED visits for accidental needle punctures were iden-
tiﬁed. Of those, 3742 (71%) were work-related (annual visits:
2001 = 1171; 2002 = 1262; 2003 = 1309). Mean age was 38
years (median: 37, range: 16–77); 75% were female. Superﬁcial
injuries accounted for 9%; 81% were coded as ﬁnger/hand/arm
wound or injury; 4% other injuries and 5% reﬂected an admin-
istrative encounter. No hospitalizations or deaths occurred.
Almost all (98%) patients were treated and released with 2%
leaving against medical advice or disposition unknown. Average
visit duration was 1.6 hours (median: 1.2) at an average visit
cost of $319 (median: $255). On average, 1699 ED hours were
utilized per year. The average total cost per year for all work-
related needle puncture visits was $418,450 with a cumulative
three year cost of roughly $840,000. CONCLUSIONS: The ED
is utilized as a primary treatment center for work-related needle
punctures, even when the injury is superﬁcial or visit occurs as
part of the administrative process. Although the risk of con-
tracting a blood-borne virus and related patient anxiety need to
be addressed when such an injury occurs, an alternative, less
resource intensive location for evaluating these injuries should
be considered, particularly in high risk areas, such as hospitals,
given ED time and cost consequences.
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OBJECTIVES: In 2003 a restrictive reimbursement scheme,
advocating increased individual reimbursement versus general
reimbursement of new important pharmaceuticals, was imple-
mented in Norway. This study was conducted 18 months after
implementation, and investigates physician self-reported atti-
tudes to and experience with the scheme from a clinical and
administrative perspective. METHODS: Practicing physicians (n
= 1399) from the NMA Research Panel were surveyed (73 ques-
tion self-administered questionnaire) by mail, December 2004.
The response rate was 71% (n = 993). Only data from respon-
dents involved with the scheme in 2004 (n = 605; 61%) were
analysed in this sub-study of 24 questions. Physicians’ attitudes
and experience were addressed through 17 claims about the
scheme and evaluated on Likert scales, in addition to questions
on resource use and number of applications, referrals and appli-
cation approvals/rejections. RESULTS: Of the 605 respondents
in this sub-study, 87% agreed that the individual reimbursement
scheme was complicated and demanding. Only 37% reported
approval of all applications. Rejected applications were appealed
by 26% of the physicians, 31% re-submitted/-referred to spe-
cialists, 22% requested written justiﬁcation, 21% recommended
patients to pay for the pharmaceutical themselves, whilst 14%
did nothing. The majority of physicians (71%) were dissatisﬁed
with the scheme and 54% were dissatisﬁed with the application-
process. In contrast, only 11% were satisﬁed with the scheme
and 14% with the application-process. Fifty-seven percent
reported that the scheme restricted physicians from prescribing
the pharmaceutical they consider clinically best for a patient and
52% of patients choose to pay for the pharmaceutical them-
selves. Self-reported use of time to administrate individual appli-
cations (n = 110,000), was estimated to 11 physician-labour
years and a cost of 42 million NOK in 2004. CONCLUSIONS:
The majority of physicians in Norway are dissatisﬁed with the
governments increased use of individual reimbursement. The
results indicate that the scheme generates high administrative
costs and may have negative consequences for patients.
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OBJECTIVE: Reform legislation has expanded the U.S.
Medicare program for eligible telemedicine services and has
required establishment of a process to add or delete covered ser-
vices on an annual basis. This study explores the current reim-
bursement status of Medicare telemedicine reimbursement and
its potential implications for 2007. METHODS: The Medicare
rationale and historic progress of telemedicine coverage and
reimbursement was constructed within a worksheet format.
Major changes and additions to the program were highlighted
and examined. A timeline of legislative and regulatory decisions
was prepared. Criteria for coverage and payment were identiﬁed
and summarized. Current deﬁnitions of required equipment and
exceptions to these requirements were identiﬁed and their evo-
lution tracked. The potential for 2007 reimbursement changes
was evaluated. RESULTS: A summary of ﬁndings follows. The
Medicare telemedicine program contains four major covered
types of service that can now be performed by eight categories
of speciﬁed professionals. Two types of geographic areas are eli-
gible, although certain demonstration programs may be eligible
regardless of geographic location. Billing and payment requires
the use of stipulated codes. The process to add or delete services
annually has been implemented. Each transaction must contain
two sites; “distant” and “originating”. There are ﬁve types of
originating sites. Payment is funded differently for “distant”
versus “originating”. The required equipment is primarily rep-
resented by interactive telecommunications systems, although
asynchronous technology is allowed in restricted instances. An
upcoming Medicare report to Congress may recommend further
expansion of the telemedicine program in 2007. CONCLU-
SIONS: Medicare telemedicine coverage and payment has con-
tinued to expand but remains restricted to certain geographic
areas and to certain service provider sites. Health care decision-
makers, including managers and payers, must be made better
aware of the multiple beneﬁts and efﬁciencies that telemedicine
offers to both service providers and to patients.
PHP36
PHARMACOEPIDEMIOLOGICAL ANALYSIS OF THE USEING
DRUGS FROM REIMBESMENT LIST IN RUSSIA
Yagudina RI1, Kulikov A1, Safﬁulin R2,Yarkaeva F2
1Moscow Medical Academy, Moscow, Russia, 2Kazan Medical
University, Kazan, Russia
OBJECTIVES: To estimate volumes and structure of consump-
tion of the drugs received by separate categories of citizens which
have the right to free-of-charge reception under reimbesment
program (DLO) in 2005 in Tatarstan (on example Tatarstan
region). To allocate diseases having the greatest prevalence and-
or the greatest ﬁnancial loading for budget. METHODS: In 2004
there was not the federal reimbursement system. In 2005 DLO
was launched. A total of 216,722 persons have the right to
receive drugs by DLO. We received the information on each of
2,543,599 purposes of drugs. Ischemic illness of heart, hyper-
tonic illness, diabetes, cancer of a mammary gland were leaders
on volume. Expenses Ischemic illness of heart, hypertonic illness,
diabetes, cancer of a mammary gland were leaders on volume 
of expense. One thousand patients with these diagnosis were 
randomized. We compared their therapy in 2004 vs. 2005.
RESULTS: Total cost of DLO in Tatarstan in 2005 was
€26,368,244. Average cost of one recipe in 2005 in DLO was
€10.5. Average expenses for one patient in 2005 a year in DLO
was €124. The maximal expenses for one patient was €23,534.
On ischemic illness of heart 7% of charges are necessary, arter-
ial hypertension 9%, diabetes 16%, oncology 19%. CONCLU-
SION: Introduction of system of reimbesment has rendered
beneﬁcial effect on quality of treatment of patients 2005 vs. 2004
percentage of patients on a regular basis received drug therapy
in occasion of cardiovascular diseases (with the miss no more
than three months for a year) has grown from 15,8% up to
32.8%.
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Engstrom A, Lundin D, Jacob J
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OBJECTIVES: To calculate a price index for pharmaceuticals in
Sweden and to examine the effects of generic competition on
patented pharmaceuticals. METHODS: Price and volume data
